Also Read | Investing during all-time highs can be good strategyBut last week, the researchers told about 20 universities that were considering participating in the study that it wouldn’t move forward yet, according to people involved in the effort.
The researchers weren’t able to secure federal funding for the trial, which would have cost several hundred million dollars, and faced time constraints in getting the complex study up and running so it could yield results before students ended the spring semester, these people said.“In the end, there just wasn’t enough support to get it off the ground at this point in time," said Myron Cohen, director of the Institute for Global Health and Infectious Diseases at the University of North Carolina..